Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Orthopediatrics (KIDS) over the last 7 years, with Q3 2025 value amounting to -$0.5.

  • Orthopediatrics' EPS (Weighted Average and Diluted) fell 4705.88% to -$0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.96, marking a year-over-year decrease of 5934.96%. This contributed to the annual value of -$1.64 for FY2024, which is 7814.11% down from last year.
  • Latest data reveals that Orthopediatrics reported EPS (Weighted Average and Diluted) of -$0.5 as of Q3 2025, which was down 4705.88% from -$0.3 recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' EPS (Weighted Average and Diluted) ranged from a high of $0.87 in Q3 2022 and a low of -$0.7 during Q4 2024
  • Over the past 5 years, Orthopediatrics' median EPS (Weighted Average and Diluted) value was -$0.3 (recorded in 2023), while the average stood at -$0.24.
  • Data for Orthopediatrics' EPS (Weighted Average and Diluted) shows a peak YoY increase of 89090.91% (in 2022) and a maximum YoY decrease of 1000174.22% (in 2022) over the last 5 years.
  • Over the past 5 years, Orthopediatrics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.0 in 2021, then plummeted by 10001.74% to -$0.37 in 2022, then grew by 21.62% to -$0.29 in 2023, then crashed by 140.1% to -$0.7 in 2024, then rose by 28.19% to -$0.5 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.5 in Q3 2025, compared to -$0.3 in Q2 2025 and -$0.46 in Q1 2025.